Daneshvar E, Tavakolpour S, Mahmoudi H, Daneshpazhooh M, et al. Elevated serum level of B-cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B-cell depletion therapies combined with anti-BAFF agents. Int J Dermatol 2023;62:567-574.
PMID: 35894225